0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Targets for Antibody-Drug Conjugates

Targets for Antibody-Drug Conjugates

Targets for Antibody-Drug Conjugates
Background

ADCs (Antibody-drug conjugates) are highly targeted biopharmaceutical drugs that combine monoclonal antibodies specific to surface antigens with highly potent anti-cancer agents linked via a chemical linker, while sparing normal cells from damage, potentially minimizing the side effects associated with cancer therapy. Currently, there are nine approved drugs on the market.

Hot targets
TROP-2
                   
Nectin-4
                   
EGFR
                   
Her2
                   
CEACAM-5
                   
CD79B
                   
FOLR1
                   
Siglec-3
                   
BCMA
                   
Siglec-2
                   
CD19
                   
CD30
                   
DLL3
                   
PTK7
                   
Coagulation Factor III
                   
Coagulation Factor III
                   
ROR1
                   
ENPP3
                   
LIV-1
                   
HGFR
                   
NCAM-1
                   
EGFRvIII
                   
CD133
                   
LY75

Free samples for ADC hot targets are available!

Get it now

ACROBiosystems has developed a series of products with different species and tags for a variety of hot targets, which are suitable for immune, antibody screening, SPR, cell activity detection and other experiments. ACROBiosystems is committed to assisting you in drug development, and all SPR&BLI protocols are available for free. In addition, over expressed cell lines and kit products will be coming soon.

Product list

Anti-MMAE antibodies are coming soon! If you are interested in our product, please contact us

Product Features

High purity verified by MALS

Fig1.The purity of Human Her2, His Tag (Cat. No. HE2-H5225) is more than 90% and the molecular weight of this protein is around 80-95 kDa verified by SEC-MALS.

Fig 2.The purity of Human EGF R, His Tag(Cat. No. EGR-H5222) is more than 90% and the molecular weight of this protein is around 90-115 kDa verified by SEC-MALS.

High affinity validated by SPR&BLI

Fig 3.Trastuzumab captured on CM5 chip via anti-human IgG Fc antibodies surface, can bind Human Her2, His Tag (Cat. No. HE2-H5225) with an affinity constant of 1.07 nM as determined in a SPR assay.

Fig 4.Loaded Trastuzumab on AHC Biosensor, can bind Human Her2, His Tag (Cat. No. HE2-H5225) with an affinity constant of 0.825 nM as determined in BLI assay.
 

Fig 5. Cetuximab captured on CM5 chip via anti-human IgG Fc antibodies surface, can bind Human EGF R, His Tag (Cat. No. EGR-H5222) with an affinity constant of 1.3 nM as determined in a SPR assay.

Fig 6.Loaded Cetuximab on AHC Biosensor, can bind Human EGF R, His Tag (Cat. No. EGR-H5222) with an affinity constant of 1.23 nM as determined in BLI assay.
 

This web search service is supported by Google Inc.

totop